Diagnostics Startups Take On Growing Threat of Antibiotic-Resistant Bugs

  24 January 2020

A new breed of diagnostic companies is rolling out technologies to tackle a growing and deadly health-care problem: antibiotic-resistant bugs.

More than 35,000 Americans die annually from drug-resistant bacterial and fungal infections, according to a November report from the Centers for Disease Control and Prevention. And 270,000 people die annually from sepsis, an overwhelming response to an infection, according to the National Institute of General Medical Sciences.

Further reading: WSJ PRO Private Equity
Author(s): Brian Gormley
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Evotec

JSS University





Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!